Resource

 

 

 

 

 

 

 

 

 

 

 

Banking & Finance - Capital Markets: Equity

Welkin Raises $160 Million for Welkin Capital Partners II

25 Aug 2017

Simpson Thacher represented Welkin in connection with the formation of Welkin Capital Partners II. The fund reached a final close in August 2017 with $160 million in commitments. Welkin is a China-focused growth equity investment firm with a distinguished family heritage and strong entrepreneurial roots in the region.

The Simpson Thacher team consisted of Adam Furber and Michael Ceulen (Investment Funds); Katharine Moir and Sarah Katz (Tax); and Jeanne Annarumma (ERISA).

YY Inc. Follow-On ADS Offering

21 Aug 2017

Davis Polk advised the underwriters in a registered shelf takedown of 6,612,500 American Depositary Shares by YY Inc. The total proceeds of the shelf takedown were approximately $442 million.

YY Inc. is a NASDAQ-listed company and a live streaming social media platform in China. YY Inc. engages users in real-time group activities through online live media on PCs and mobile devices.

DLA Piper advises underwriters in YogaWorks IPO

21 Aug 2017

DLA Piper represented the underwriters in the US$40 million initial public offering of YogaWorks, Inc. (NASDAQ: YOGA). YogaWorks is one of the largest and fastest growing providers of high quality yoga instruction in the United States. Cowen and Company, LLC, Stephens, Inc. and Guggenheim Securities, LLC acted as joint book-running managers for the offering. Roth Capital Partners, LLC acted as lead manager and Imperial Capital, LLC acted as co-manager.

Celltrion Healthcare Completes US$900 Million IPO

17 Aug 2017

Simpson Thacher represented Celltrion Healthcare Co., Ltd. (“Celltrion Healthcare”) in connection with the initial public offering of 24,604,000 shares of its common stock. The offering raised Won 1.01 trillion (approximately US$900 million) in gross proceeds for Celltrion Healthcare. The common shares of Celltrion Healthcare were listed on the KRX KOSDAQ Market of the Korea Exchange and offered by Celltrion Healthcare as a registered IPO in Korea and in reliance on exemptions under the U.S.

Haavind is assisting Axactor with a NOK 598 million private placement and co-investment partnership with Geveran Trading

16 Aug 2017

Haavind advisor to Axactor in connection with co-investment partnership with Geveran.

Haavind is assisting Axactor AB (publ) with a NOK 598 million private placement of shares in order to fund Axactors Equity investment in a portfolio investment company to be established together with Geveran Trading Co. Limited, a company indirectly controlled by Mr John Fredriksen (Geveran). The investment partnership will secure EUR 300 million in investment capacity.

Clifford Chance advises syndicate of lenders on the pre-IPO refinancing of Vapiano

15 Aug 2017

Clifford Chance has advised UniCredit Bank AG on the EUR 200 million syndicate of financing for Vapiano SE via an international syndicate of lenders. This new financing allows for existing financing arrangements to be repaid and will also fund the continued growth of the Vapiano Group. The financing is a key step towards Vapiano's IPO. The initial listing occurred on 27 June 2017.